利伐沙班片
所屬分類
國(guó)際原料藥
Rivaroxaban Tablets
產(chǎn)品詳情
Rivaroxaban Tablets
Indication:
-to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
-for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and for the reduction in the risk of recurrence of DVT and of PE
-for the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
Original company: Bayer
Original brand: Xarelto
上一頁(yè)
下一頁(yè)
上一頁(yè)
下一頁(yè)